UPDATE | December 21, 2023

How to overcome biopharma industry challenges

  • MAIL

MEDIA FOCUS - How to overcome biopharma industry challenges


CDMOs are enhancing efficiency, flexibility, and scalability amid a rising demand for biologics, evolving patient needs, and changing regulatory standards. In this article, Kevin Sharp, Senior Vice President and Head of Global Sales, shares his insights on how partnering with a CDMO can help biotech companies tackle manufacturing challenges and uncertainties.

Read more

MEDIA FOCUS - How to overcome biopharma industry challenges

CDMOs are enhancing efficiency, flexibility, and scalability amid a rising demand for biologics, evolving patient needs, and changing regulatory standards. In this article, Kevin Sharp, Senior Vice President and Head of Global Sales, shares his insights on how partnering with a CDMO can help biotech companies tackle manufacturing challenges and uncertainties.

Read more  

  • CDO
  • CGMP
  • ADC
  • Bio Campus
  • IR
  • CMO

Share article

  • MAIL

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required